Burning questions about the future of prescribing drugs online; exclusive on new Senate FDA legislation

As new digital pharmacy companies crop up, here's what we know — and still don't know — about telehealth prescribing. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by         STAT+: 3 burning questions about the future of prescribing drugs online By Mohana Ravindranath Adobe As new digital pharmacy companies crop up, here's what we know — and still don't know — about telehealth prescribing. Read More STAT+: Senate FDA legislation will include dietary supplement, cosmetic reforms By Nicholas Florko Adobe Lawmakers are set to unveil draft legislation that will reform the FDA’s regulation of dietary supplements and cosmetics, sources told STAT. Read More Opinion: The case of RaDonda Vaught highlights a double standard for nurses and physicians By Michelle Collins and Cherie Burke Nicole Hester/The Tennessean via AP, Pool The conviction and sentencing of former nurse RaDonda Vaught for making a common error are a travesty of justice. Read More Sponsor content by SANOFI AND REGENERON Looking beyond "allergic" and "eosinophilic" views of moderate-to-severe asthma Growing evidence shows type 2 inflammation contributes to most asthma cases in children and adults, going beyond perceptions that asthma is only triggered by allergies or driven by eosinophils. This underlying inflammation can increase disease burden in moderate-to-severe asthma, including worsened lung function and OCS dependency. Discover Sanofi and Regeneron's work in type 2 inflammation and explore the latest asthma research at the ATS Annual Meeting (May 13-18). STAT+: Real estate firms own nearly 1 in 10 health care properties By Bob Herman Adobe New data provide a fresh look into the world of REITs — which essentially act as landlords to hospitals, nursing homes, and other providers. Read More Opinion: The man behind 'value-based pricing' saw pharma distorting his message — and walked away By Billy Kenber Courtesy Donna Criswell Drug companies turned to Mick Kolassa for advice on how to price a drug. Price gouging and greedy execs nudged him to back away. Read More Opinion: Turn off the spigot for hospitals' Covid-19 relief funding By Ge Bai and Brian Blase Adobe Covid-19 relief funding helped hospitals get through the worst of the pandemic — and then some, giving them higher profit margins. Read More Friday, May 13, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser